HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles Kemmler Selected Research

GI 5005

2/2007Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles Kemmler Research Topics

Disease

1Neoplasms (Cancer)
02/2007

Drug/Important Bio-Agent (IBA)

1GI 5005IBA
02/2007
1Proteins (Proteins, Gene)FDA Link
02/2007